# Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease

Study · id `cardio:ct-nct03535935` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03535935](<https://clinicaltrials.gov/study/NCT03535935>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03535935

Browse, organ or system: Kidneys; Metabolism  
Browse, condition area: Diabetes and metabolic disease; Kidney connections  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 118 participants.

## Technical summary

Registry record NCT03535935. Randomized; single masking; primary purpose treatment. Start 2018-07-01 (actual); primary completion 2022-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 118 participants (planned count; ClinicalTrials.gov record NCT03535935, source copy `cardio:ctgov-nct03535935-2020-12-07`, retrieved 2026-10-26)
- Started: 2018-07-01 (actual) (ClinicalTrials.gov record NCT03535935, source copy `cardio:ctgov-nct03535935-2020-12-07`, retrieved 2026-10-26)
- Primary completion: 2022-06-30 (anticipated) (ClinicalTrials.gov record NCT03535935, source copy `cardio:ctgov-nct03535935-2020-12-07`, retrieved 2026-10-26)
- Completion: 2022-12-31 (anticipated) (ClinicalTrials.gov record NCT03535935, source copy `cardio:ctgov-nct03535935-2020-12-07`, retrieved 2026-10-26)
- Countries: Hong Kong SAR China (ClinicalTrials.gov record NCT03535935, source copy `cardio:ctgov-nct03535935-2020-12-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03535935-2020-12-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease
- Acronym: READY
- Condition: Diabetic Nephropathies
- Condition: Diabetic Kidney Disease
- Intervention (Drug): Astragalus Powder
- Intervention (Other): Routine medical care (active comparator)
- Lead sponsor: The University of Hong Kong
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Diabetic kidney disease (`cardio:diabetic-nephropathy`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: The University of Hong Kong (`cardio:org-the-university-of-hong-kong`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Add-on astragalus in type 2 diabetes and chronic kidney disease: A multi-center, assessor-blind, randomized controlled trial (`cardio:pubmed-38810556`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 426f1e255f9ab38999cff9fc7a4d4e133e91a228cf3fff4fca702d9022c01a13
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
